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Inhaled anesthetics used in surgeries are typically volatile halogenated hydrocarbons. In a typical 
situation only 5% of the administered anesthetic is metabolized by the human body, while the 
remaining 95% is exhaled through the ventilation systems eventually into the environment as it is. 
The anesthetics contribute to global warming and stratospheric ozone depletion. This research 
focuses on using advanced oxidation processes as a treatment system for the common anesthetic 
gases namely Halothane, Sevoflurane and Isoflurane. 
The first step was to determine an appropriate reactor setup which could contain the light source 
and the catalyst medium with an accessible sampling port. The loss of anesthetic gas due to leaks 
and wall effects were measured and considered to be a baseline for further tests. In developing a 
treatment system, UV-photolysis, UV-ozonation, and UV-photocatalysis were tested in different 
batch experiments using Halothane, and UV-photocatalysis was found to be the most effective 
advanced oxidation process among the ones tested. Since UV-photocatalysis was efficient in 
degrading ~ 99.9 % of the anesthetic gas in 20 min, the influence of several parameters such as the 
type of catalyst, the type of catalyst support surface, the catalyst loading, the incident light 
wavelength, the power of the incident light, catalyst surface area illuminated, inlet reactant 
concentration and the moisture content on the degradation efficiency of UV-photocatalysis was 
tested. Based on the results obtained UV-photocatalysis with the appropriate conditions was used to 
test the degradation of Isoflurane and Sevoflurane. 
The post oxidation contents of the reactor with Isoflurane and Sevoflurane were measured using Ion 
Chromatography for their anion concentration and a possible degradation mechanism was suggested 
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1. Introduction and Literature Review 
1.1.Anesthetic gases 
New modern anesthetics are made of halogenated hydrocarbons or ethers that are often liquid at room 
temperature and are evaporated using a vaporizer before inhalation. Commonly used anesthetics are 
Halothane (2-bromo-2-chloro-1,1,1-trifluoroethane), Isoflurane (2,2,2-trifluoro-1-chloroethyl difluoro 
methyl ether), Desflurane (1,2,2,2-tetraflurorethyl difluoromethyl ether), Sevoflurane (1,1,1,3,3,3-
hexafluoro-2-fluoromethoxy propane) and nitrous oxide. Halothane was the first fluorinated inhaled 
anesthetic to rapidly replace all the other potent inhaled anesthetics. Efforts to develop a rather ideal 
volatile anesthetic eventually led to the invention and use of Desflurane, Sevoflurane and Isoflurane. 
Halothane is currently being predominantly used only in developing nations. N2O is the only non-
volatile gas which is administered in the gaseous state at room temperature.1 
An ideal inhaled anesthetic agent property include ample potency, resistance to physical and metabolic 
degradation, odorless to inhale, rapid in onset and offset, low solubility in blood and tissues and a 
protective effect by preventing lack of injury to vital tissues. Other characteristics include a lack of 
ability to cause seizures and respiratory irritation and low acquisition cost. An ideal anesthetic is 
difficult to obtain, while many have suitable characteristics. The currently used anesthetic gases 
undergo very little in-vivo metabolism during inhalation. 
 
1.1.1.Halothane 
Halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) is a volatile anesthetic gas with a boiling point of 




and Desflurane) because it is susceptible to inducing adverse effects, namely hepatic necrosis.2 Due to 
its low cost and easy availability, Halothane was used for many initial experiments in this study. Since 
Halothane’s physiochemical properties are similar to the other halogenated anesthetics the experiments 
often gave similar results when repeated with the other anesthetics.  
 
1.1.2.Sevoflurane 
Sevoflurane (fluoromethyl 2,2,2-trifluoro-l(trifluoromethyl) ethyl ether) is a non-flammable and non-
explosive liquid administered by vaporization. Sevoflurane is a colorless liquid containing no 
additives. It is a non-pungent liquid miscible with organic solvents and is slightly soluble in water. 
Sevoflurane with a boiling point of 58.6oC is often bottled in amber glass bottles with water to prevent 
degradation. The fast offset/onset and low irritation to the mucous membranes makes Sevoflurane a 




Isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1- trifluoro-ethane) with a boiling point of 48.5oC is a 
non-flammable liquid administered by vaporizing. It is a clear colorless stable liquid containing no 
chemical additives. It can be stored in glass bottles under indirect sunlight for almost 5 years with no 
change in composition. It has a mildly pungent and musty odor. Isoflurane is administered with 
another drug, usually Propofol, to induce stable general anesthesia.4 The use of Isoflurane has 





Desflurane (1,2,2,2-tetrafluoroethyldifluoromethyl ether) is a polyfluorinated methyl ethyl ether that is 
almost identical to Sevoflurane. The complete fluorination greatly reduces its blood solubility 
coefficient and potency. The low boiling point of Desflurane (23.35oC) requires a highly specialized 
vaporizer. Desflurane is the most pungent of all the inhaled anesthetics. This property of Desflurane 
increases the risk of cough, laryngopasm.5 Hence, despite its quick recovery, it has limited practical 
use. 
 
1.2.Environmental Implications of Anesthetic Gases 
The atmosphere can be subdivided based on its temperature profile. The lowest layer where the 
temperature decreases with increase in altitude is called the troposphere. The layer above it is called 
the stratosphere where the temperature increases up to a distance of 50 km. The layer of ozone in the 
stratosphere often referred to as the stratospheric ozone acts as a shield from the harmful UV 
radiations of the sun. 
This stratospheric ozone layer is damaged by the long living chlorine and bromine free radicals which 
are released due to human activities. The use of CFCs and Halons were eventually regulated as part of 
the Montreal Protocol. 
A class of halogenated compounds that have been in use in medicine without regulations are the 
halogenated anesthetic gases mentioned above. The global warming potential of these gases which is 
defined as the measure of the gas’ ability to trap heat when compared to CO2 over 100-year time 





These anesthetics are often exhaled almost as it is by the patient. Their rates of in vivo metabolism are 
0.2%, < 0.02%, 5 % for Isoflurane, Desflurane and Sevoflurane respectively and ~20% for Halothane.7 
These anesthetics are administered via a system 
that mixes them with a carrier gas specifically 
oxygen and nitrous oxide. In addition to the 
exhaled gases, the anesthetics also escape through 
leaks in the vaporizer or outdated equipments. 
Because currently there are no mandatory waste 
anesthetic gas capture systems, these gases are 
entirely vented to the outside environment through 
the ventilation systems. 
As of 2009, a typical large US hospital is said to 
use 1081, 505, and 6 liters of Isoflurane, 
Sevoflurane and Desflurane respectively.  
Figure 1.1: Global emissions trend of modern anesthetic gases7 
 
Around 5% of the anesthetic is metabolized by the patient while the remaining anesthetic is released 
via the ventilation system, untreated into the environment. This growing anesthetic gas usage trend 
shown in Fig 1.1 predicts a total CO2 eq emission of 3.16 million t/yr in 2014 alone where the total 
global carbon dioxide emission was 9.79 giga tonne. This CO2 eq emission of  3.16 million t/yr in 
2014 is equal to almost 33.3% of the emissions from all the Swiss passenger car fleets for that year.7 




Earth’s energy balance. Although these anesthetic gases occur in concentrations million times lower 
than that of CO2, they are responsible for a radiative forcing of 0.3 W/m
-2. These halogenated organics 
absorb strongly in the infrared region of the 
electromagnetic spectrum (600-1400cm-1).  
This region also known as the atmospheric 
window is used by the earth to radiate the excess 
IR energy back to the outer space. These 
anesthetics strongly absorb these emitted IR 
radiations, causing an imbalance in the earth’s 
energy budget as shown in Fig 1.2.8 
This work when put to practice will help reduce 
or eliminate these anesthetic gases from being 
released untreated into the environment thus 
preventing damage. 
Figure 1.2:Anesthetic gases with maximum absorbance in the atmospheric window 
 
 
1.3.Advanced Oxidation Processes 
Advanced oxidation processes (AOPs) were initially proposed for potable water treatment in the 
1980s. They predominantly use powerful oxidizing agents like hydroxyl or sulphate radicals. These 




and disinfection. Although AOPs have been studied in 
detail for wastewater treatment, they are rarely 
employed for gas treatments. The OHo radical is a non-
selective yet strong chemical oxidant that once 
produced, attacks nearly all oxidizable organic 
complexes.  
 
Table 1:Relative oxidizing power of selective oxidizing groups 
Since the lifetime of the radical is very small it is mostly generated in-situ from hydrogen peroxide, 
ozone, photo-catalysis or oxidants alongside UV radiation. Attack by the OHo radical can diminish the 
pollutant concentration from parts per million to as low as parts per billion. Table 1 clearly shows that 
the relative oxidizing power of the OHo is much higher than the other oxidizing agents.9 The major 
advantage of AOPs is allowing simultaneous treatment of multiple contaminants. This occurs due to 
the presence of highly non-selective but efficient oxidants. There are several types of AOPs that 
degrade the pollutants, specifically hydroxyl based AOPs, ozone based AOPs, UV based AOPs, fenton 
based AOPs, sulphate radical based AOPs, and sonolysis.  
The current work focuses on three such ways: UV-photolysis, UV-photocatalysis, and UV-ozonation. 
1.3.1.UV-Photolysis 
Photodegradation generally employs a low or medium pressure mercury lamp emitting strong UV 
radiations at different wavelengths. There are two pathways for the degradation induced by UV 




of incident UV photons. This breakdown occurs due to the cleavage of one or more covalent bonds in 
the molecule due to the absorption of light energy. 10 The other pathway is photo-oxidation where the 
reactant molecule is excited in the presence of UV light and subsequently results in an oxidation 
reaction.10 Photodegradation by UV treatment was first used for wastewater treatment and suggested 
for waste gas treatment in the early 1990s.11,12 In the past two decades, UV-photodegradation has 
gained attention due to its simplicity however its widespread use has been limited due to the higher 
costs associated with it. 
 
1.3.2.UV-Ozonation 
Ozone, when compared to the saturated calomel electrode, has a very strong oxidizing potential of 
2.07 V.13 Ozone (O3) readily absorbs UV radiations emitted at the 254 nm wavelength producing H2O2 
as an intermediate, which further decomposes to produce hydroxyl radicals. The reactions below 
depict the mechanism of pollutant degradation in UV-ozonation: 
 O3+hv→O2+O                                                                 ………………………………Equation 1 
 O+H2O→ H2O2                                                               ………………………………Equation 2 
 H2O2→2OH
o                                                                   ………………………………Equation 3 
This process is highly energy and cost consuming. Generating ozone is the most cost consuming part 
of UV-ozonation. 
1.3.3.UV-Photocatalysis: 




catalyst as depicted in Fig 1.3. Titanium dioxide (TiO2) and zinc oxide (ZnO) are the most commonly 
used industrial catalysts.  
The catalyst particles in the presence of light photons are 
excited when the incident energy is greater than the band 
gap energy of the catalyst. This excitation produces valence 
band holes (hvb+) with an oxidative capability and 
conduction band electrons (ecb-) with a reductive capability. 
Figure 1.3: Mechanism of UV-photocatalysis14 
When the excitation energy is sufficient enough to prevent electron-hole recombination, the holes 
reach the surface of the catalyst to combine with water molecules to form adsorbed hydroxyl radicals. 
These OHo radicals leave the bulk to form free radicals that take part in the oxidation of the reactant 
species as shown below: 
 TiO2 + hν → ecb
-+ hvb+                                                                ……………………..Equation 4 
 ecb-+ hvb+→ heat                                                                           …………………….Equation 5 
 hvb++ OH-ads → OH
o
ads                                                                  …………………….Equation 6 
 hvb+ + H2O → H2O
+→ H+ + OHofree                                             …………………….Equation 7 
Even though the catalyst used is often non-toxic, cheap, chemically and biologically inert and very 
efficient in the anesthetic degradation, the recovery of the catalyst is often a major problem and the 






The current research work aims at testing the possibility and efficiency of degrading the waste 
anesthetic gases emitted from medical facilities using selective advanced oxidation processes. 
1.5.Relevance 
The main motive behind this work was to identify an efficient oxidation technique which can be used 
as a treatment system to prevent any untreated halogenated anesthetic gas being released into the 
environment directly. Advanced oxidation processes have gained immense success in treating 
wastewater; however, not much work has been done in using them in treating anesthetics. Hence, to 
maintain novelty, three of the most commonly used AOPs were tested primarily with Halothane which 
was not only cheap and abundantly available but has similar physical and chemical properties as the 
other three anesthetics. Based on the results obtained, the same experiments were then conducted with 
the other two anesthetic gases namely Sevoflurane and Isoflurane. The results obtained were 
normalized for comparison since, for the same inlet volumes of the different anesthetics the 
concentration obtained in the GC results were different due to variation in their densities, their boiling 
points, their vaporization rates and their reactivity with the surfaces of the reactors and GC analytical 
equipment. The anesthetic gas concentrations obtained were analyzed in terms of reaction rates to 
obtain a deeper insight into the degradation. 
 
1.6.Overview 
The introduction and literature review section briefly details the common anesthetic gases in use 




advanced oxidation processes used in this study. The introduction is followed by a detailed literature 
review on the various applications of advanced oxidation processes in treated pollutants in liquid and 
gas streams. It elaborates the influence of each parameter on the degradation efficiency and also 
broadly outlines similar studies done by other researchers in degrading the anesthetic gases. The 
materials and methods section talks about the materials used, experimental setup and the analysis 
techniques used in this study. The experimental section focuses on documenting the results and 
providing an explanation for the observations. The conclusions and future work talks about the 
inference from the work done and how best the work can be carried forward for the benefit of the 
environment.  
Anesthetic gases are one of the typical pollutants created in an operation room.15,16,17 These anesthetic 
gases are present in the air normally due to leaks in the breathing circuit, respiration by the patient, due 
to accidental spills or poor practices. Chronic exposure to anesthetic gases can cause kidney diseases, 
irritation in the mouth, skin and throat and also increase the risk of congenital 
abnormalities.15Anesthetic gas concentrations above the occupational exposure limits are a reality 
which is primarily caused due to inefficient ventilation systems or poor work practices.15 
Advanced oxidation is an energy efficient technology that consists of generating oxidizing species that 
have the potential to convert the pollutants into substances like carbon dioxide and water. Numerous 
studies have shown that it is feasible to remove pollutants using photocatalytic oxidation. 
In the current times, even though there are many studies on the photocatalytic oxidation of aqueous 
contaminants18-26 the studies in the gas phase are very limited.27,28 Even though many kinds of 
pollutants like alkanes, ketones, aromatics and chlorinated hydrocarbons can be removed from air using 
photocatalytic oxidation29-40, their application has been limited due to problems with deactivation of the 




photocatalysis.50,51 TiO2, due to its high catalytic degradation efficiency, lower cost and non-toxicity is 
widely used in photocatalysis.52ZnO was tested as another potential photocatalyst since it also has high 
photosensitivity, stability, strong oxidizing power, is non-toxic and has a large band gap. A major 
reason for choosing ZnO alongside TiO2 for comparison is their similar band gap energy of 3.26 and 
3.33 eV respectively. Many researchers have focused their work in developing non-TiO2 catalysts with 
low or similar band gaps as TiO2such as ZnO, Fe2O3, ZnS and, CeO2.
50,53-57 In some research work, 
ZnO has shown better degradation for dyes in aqueous solutions than TiO2.
58-63 Some research work 
states that dopants have the ability to cause photogenerated electron-hole recombination thus affecting 
the efficiency of photocatalysis.52 
Fiberglass cloth has emerged as a promising catalyst support surface since it is lightweight, has a low 
cost and is highly stable against UV light.64,65 It can also be folded and cut into many shapes. 
The performance of photocatalytic oxidation can be studied in two forms: process parameters (air 
velocity, light intensity, amount of catalyst) and environmental parameters (pollutant initial 
concentration, moisture). The influence of these factors has been extensively studied in Literature.66-72 
Just like the other advanced oxidation processes, photodegradation was first considered for waste water 
treatment and later found more suitable for waste gas treatments in 1990s.11,12 Photodegradation gained 
much popularity in the last two decades in contrast to photocatalysis due to the formation of 
intermediates on the catalyst surface that subsequently reduce the catalytic activity with time.73,74 
Most of the studies have been performed on everyday home and office pollutants like toluene and 
benzene while very little attention has been paid to treat the specific hospital pollutants.75 The selective 
research that has been done on treating anesthetic gases is focused on using photocatalytic oxidation to 
study only one particular anesthetic gas.75,76,77 To the best of the author’s knowledge, no research work 
has been conducted to compare the anesthetic gas degradation efficiency of three advanced oxidation 




The objective of this work was to evaluate the performance of three advanced oxidation processes: 
photolysis, ozonation, and photocatalytic oxidation in degrading three anesthetic gases: Halothane, 
Isoflurane, and Sevoflurane. The performance of photocatalytic oxidation was studied by varying the 
pollutant inlet concentration, incident light wavelength, power of the light source, type of catalyst, type 
of catalyst support surface, catalyst surface area illuminated, reactant inlet concentration, amount of 





















OBJECTIVES OF THE CURRENT RESEARCH 
 Since anesthetic gases are found to affect the environment adversely, the current research work aims to  
1. Design a reactor and set up a batch system to carry out the designed experiments 
2. Compare the efficiency of three advanced oxidation processes in degrading the anesthetic gas 
3. Test the influence of the type of catalyst on the anesthetic gas degradation rate using UV-
photocatalysis 
4. Test the efficiency of UV-photocatalysis in degrading the anesthetic gas by varying the catalyst  
support surface. 
5. Test the influence of incident light source wavelength on the anesthetic gas degradation rate 
6. Test the influence of the power of the light source on the anesthetic gas degradation rate 
7. Test the effect of catalyst area illuminated by the light source on the anesthetic gas degradation 
rate 
8. Determine the anesthetic gas degradation rate at various inlet concentrations 
9. Determine the anesthetic gas degradation rate at various amounts of catalyst loading 






2. MATERIALS AND METHOD 
 
2.1.Chemicals: 
AEROXIDE TiO2 P25 was purchased from Evonik in the form of a nanopowder with a primary 
particle size of 21 nm as established from analysis by TEM and a surface area of 35-65 m2/g as 
established from analysis by BET.78 It was used as purchased without modification. Zinc oxide in the 
form of a 99.9% metal basis with a -200 mesh powder size purchased from Alfa Aesar was used 
without any further treatment. FORANE (isoflurane, USP) was purchased from Baxter Corporation in 
100 mL amber colored glass bottle. Halothane was purchased from Sigma Aldrich in 125 mL amber 
bottles. Sevoflurane was purchased from AbbView Corporation. A sample of Desflurane was provided 
by Class 1 Inc.  All the anesthetic liquids purchased were used without any further treatment. 
 
2.2.Photocatalytic Reactor: 
The photocatalytic oxidation experiments were performed in a 3.8 L (46.736 cm length x 10.16 cm 
diameter) annular reactor constructed of black ABS plastic and operated in a batch mode (Fig 2.1). 
The non-removable end of the reactor was covered thrice with duct tape to minimize the leaks. The 
removable end had a two or four pin lamp holder fixed on its inside. The rear end of the holder was 
taped firm to minimize the leaks. This annular reactor was chosen for its combination of simple 
geometry, low pressure drop and good accessibility to light. Even though this type of reactor is not 
designed for high air flow rates they are useful in testing the kinetic parameters.79 The reactor used for 
these experiments was equipped with a sampling septum on the top center that allowed for injection 




Masterflex peristaltic pump equipped with a 60 cm length of 17 Norprene tubing with a 6.4mm inner 
diameter. A piece of 370 cm long polytetrafluoroethylene (PTFE) tubing was used for recirculation 
with the pump rate set at 500 ml/min. This flow rate meant that one full volume of the reactor would 
be circulated in approximately 7.6  min. The media and the lamp were housed inside the reactor. Three 
different light sources were used for the experiment. One 18W 254 nm UVC lamp with dual 
fluorescent tubes (Phillips TUV PL-L/4P series) each tube having a diameter 39 mm and length of 325 
mm was used. A  9W 254nm UVC lamp with dual fluorescent tubes (Phillips TUV PL-S/2P series) 
and a 9W 365 nm UVA lamp with dual fluorescent tubes (Phillips PL-S/2P series) both having a tube 
diameter of 28 mm and length of 210 mm were also used. The light sources were connected to an 
external control source to turn the power on/off when required. Residual reactants and degradation 
products in the reactor and on the photocatalytic media were removed by flushing compressed air with 
11% relative humidity through and over each component for 60 min before each experiment.80 
 
Figure 2.1: Schematic representation of the photocatalytic reactor 
 
The photocatalytic media used were prepared by deposition (painting with a brush) of the catalyst 




mentioned, onto a polished 30 cm wide × 25cm long x 1 mm thick aluminum support that was 
subsequently dried overnight at ambient conditions. This process was repeated until the required 
amount of catalyst was deposited on the support surface as determined by measuring the change in the 
dry weight. 
2.3.Fabricating Media with Different Support Surfaces 
Here the main goal was to compare the photocatalytic results obtained, using the closed-loop reactor, 
with (i) a flat aluminum sheet (ii) a fiberglass cloth mesh and (iii) a fiberglass cloth mesh supported on 
the aluminum sheet, with each medium coated with the same amount of TiO2.This ensured that each 
material was tested under similar appropriate conditions and the comparison was not biased. 
In case of the flat aluminum sheet, the medium was prepared as mentioned in Section 2.2.In the second 
case, a fiberglass cloth mesh of the same size as that of the flat aluminum sheet, 30 × 25 cm, was used 
as a support surface for TiO2. The cloth was initially weighed and the required amount of TiO2 and 
water suspension was coated onto the cloth until the required change in the dry weight was attained. 
The catalyst coated cloth was dried overnight at ambient conditions before being tested. 
 




The fiberglass cloth mesh fixed on the flat alumina sheet with plastic clips was tested as the third 
support surface. The combination of fiberglass cloth and the aluminum sheet were initially weighed 
and coated with the required amount of catalyst suspension until the desired weight change was 
observed. This setup was dried overnight at ambient conditions and tested the following day. 
 
2.4.Sampling and Analytical Methods 
The anesthetic gases throughout the experiments were quantified using a gas chromatograph (HP5890 
Series II) with a 30m long 0.53mm in diameter RTX502.2 capillary (Restek, Pennsylvania) column as 
shown in Fig 2.3. The GC is equipped with a split/splitless injector, a FID (flame ionization detector) 
and an ECD (electron capture detector). Hydrogen and air were used as the detector gases with a flow 
range of 29 ml/min and 310 ml/min respectively. Nitrogen was used as the makeup gas. The flow rate 
through the column was set to 6-7 ml/min. The oven was set to a static temperature of 60oC with no 
ramp up. 
The RTX 502.2 column was often exposed to multiple gases and impurities during experiments. 
Running an air blank often showed a few peaks in the chromatogram resulting from residual 
contaminants not eluting from previous experiments. Hence, before beginning each day’s experiments 





Figure 2.3: HP5890 series II gas chromatograph used to quantify the anesthetic samples 
 
The peaks in the gas chromatograph were sufficiently separated with retention times of 0.54 for 
Desflurane, 0.56 min for Sevoflurane, 0.62 min for Isoflurane and 0.75 min for Halothane. The peaks 
in the gas chromatograph were easily identifiable since no experiments were conducted with a mixture 
of two or more anesthetic liquids. 
2.4.1.GC Calibration 
Before conducting any experiments, the GC was calibrated with the anesthetic gas to be tested using 
the following methods. 
2.4.1.1.Air Blanks 
Before any sample injection for calibration, 500 µl of room air was injected as a blank to determine the 





Figure 2.4: Air blank showing background noise in the absence of any sample 
 
Air blanks were also run midway in the experiment to determine the amount of carry-over anesthetic 
adhered, if at all, to the teflon tip of the sample injection plunger. To avoid carry-over, the syringe was 
flushed multiple times and the teflon plunger was placed near the FID heater to volatilize any carry-
over anesthetic gas. 
2.4.1.2.Halothane Calibration Data 
Calibration of the anesthetic gas was performed to provide the relationship between the area count and 
the mass of the anesthetic injected as a sample. Based on this relationship, the area count, and 
eventually the concentration of the anesthetic gas injected as a sample, was determined by the GC 
software. The anesthetic liquid volume being injected into the reactor was chosen in such a way that 
experimental gas area counts were sufficiently within the calibration curve to prevent over estimation. 
To obtain a calibration curve, a known volume of 0.5 µl of Halothane was injected into a pre-silanized 
glass bulb of 250 ml volume containing air. Air oxidation was determined to be insufficient to degrade 
the Halothane within the time frame of the calibration. However, calibration was usually performed 
within a 30 to 60-minute time period. The bulb contents were allowed to mix at room temperature for 




collected and their area counts measured using the GC. The results depicting the variation in the FID 
and ECD area counts with the Halothane amount injected are presented in Figure 2.5 and 2.7. Figure 
2.6 depicts the Halothane calibration as observed in the FID of the GC computer. 
 
Figure 2.5: Change in the GC-FID area count with increase in the injected Halothane sample mass 
 
The area counts for the blank at the retention time of the anesthetic gas with a well flushed syringe 




























Figure 2.6: Halothane calibration as observed on the FID of the GC computer 
 
 
Figure 2.7: Change in the GC-ECD area count with increase in the injected Halothane sample mass 
 
The electron capture detector is recommended for highly electronegative compounds such as 





























compounds than the FID. Due to its sensitivity it is often used for measuring highly dilute solutions 
where the resulting area counts aren’t as high as the ones depicted in Fig 2.7. 
Since the sample concentrations being tested weren’t very low and the FID gave reasonable results, the 
ECD was not needed for its sensitivity and the GC-FID was subsequently used for all further 
anesthetic gas quantifications. 
2.4.1.3.Isoflurane and Sevoflurane Calibration 
For the calibration of Isoflurane and Sevoflurane, 0.5 µl of the anesthetic in liquid form was injected 
into the 250ml silanized glass bulb and allowed to volatilize. A silanized bulb was used to minimize 
any wall effects. Various known volumes of the resulting anesthetic gas were sampled from the bulb 
and analyzed using the FID. The resulting area counts were plotted against the injected mass of 
anesthetic gas to populate the calibration curve of the anesthetic gas. This calibration curve was used 
to then measure the unknown concentrations of the anesthetics in the experimental samples. The 
results are depicted in Figures 2.8 and 2.10. Figure 2.9 and 2.11 depict the calibration of Sevoflurane 
and Isoflurane as observed on the FID of the GC computer. 
 


























Figure 2.9: Sevoflurane calibration as observed on the FID of the GC computer 
 
 































The calibration curve for Desflurane was difficult owing to its extreme volatility at room temperature.  
Desflurane boils at 23.5oC, very near to the room temperature. During the calibration using the liquid 
Desflurane, it was observed that as soon as the liquid was extracted from the bottle, it vaporized. If 
injected into the glass bulb, sampled and analyzed there was no Desflurane peak observed at 0.54 min 
retention time or subsequent sampling times. The next step was to extract 50 µl of the head space from 
the Desflurane container into the glass bulb. Even though a bit of Desflurane was detected in the 
chromatograph, the area counts dropped drastically over time suggesting loss of Desflurane to either 
the walls or the teflon plungers.   




Liquid volumes were extracted from the bottle and immediately injected into the bulb inside the 
freezer and analyzed using the GC. The Desflurane concentration again dropped drastically over time.  
It was then decided that no accurate calibration could be performed using Desflurane and any further 
attempts were made simply to mark the peak retention time. No further studies were carried out using 
Desflurane. The resulting area counts were plotted against the time to monitor the gas stability as 
shown in figure 2.12. 
 
Figure 2.12: Change in the area counts for Desflurane over the time of 30 min 
 
 
2.4.2.Wall Effects and Leaks 
The ABS photocatalytic reactor was made in-house and had a removable threaded end cap. Leaks due 
to lose fittings or loss in concentration due to absorption on the reactor walls is a common problem in 
the air phase experiments. Hence preliminary trials also called as dark reactions were carried out for all 
the anesthetic gases to determine the contribution of leaks in the system and the wall effects. The wall 
























For these tests, 5 µl of the anesthetic liquid was injected via the injection septum on the top of the 
reactor, allowed to volatilize and analyzed. The resulting anesthetic gas concentrations measured are 
depicted in Fig 2.13, 2.14 and, 2.15. 
 
Figure 2.13: Change in the Halothane concentration due to wall effects and leaks over a time of 25 min 
 
 




































































Figure 2.15: Change in the Isoflurane concentration due to wall effects and leaks over a time of 20 min 
 
It was observed that the loss due to leaks and wall effects were consistent (within the experimental 
limits) for all the three anesthetic gases tested. Around 13% of the anesthetic gas was lost to the 
surroundings during the dark reactions in 20 min. Wall effects were considered stabilized and a 
constant loss rate was achieved after 20 min when the change in anesthetic gas concentration was less 
than 0.1%. 
To further test the wall effects and leaks, various volumes of Halothane (10µl, 15µl and 25 µl) were 
injected into the photocatalytic reactor to measure the wall effects and loss due to leaks. It was noted 
that a maximum of approximately 15% of the anesthetic was lost to the surroundings before reaching 







































Figure 2.16: Variation in the wall effects with the inlet volume over the time of 35 min 
 
 
2.4.3.Absorption on the Catalyst Surface: 
Before measuring the decrease in anesthetic gas concentration due to UV-photocatalysis, the loss in 
anesthetic gas due to absorption on to the catalyst surface was measured. This loss measured was 
compared with the loss due to the dark reaction to determine the exact amount of anesthetic gas being 
absorbed onto the catalyst. This was taken as a T0 concentration for UV-photocatalysis. This will be 
explained in Section 4.1.3. 
 
2.4.4.Measuring the Absorption Spectrum of the Anesthetic Gases 
The HP 8452 Diode Array Spectrophotometer shown in Fig 2.17 was used to measure the absorption 





































measurement using this spectrophotometer. Olis GlobalWorks software was used as a user interface to 
communicate with the device. Each sample was collected in a 10 cm pathlength x 1.8 cm diameter 
cuvette and scanned for the absorbance three times in the interval of 0.01s. The resultant absorbance 
spectrum obtained was converted into a excel graph and analyzed further. 
 
Figure 2.17: HP 8452 Diode Array Spectrophotometer used to measure the absorption spectrum of 
ozone and the anesthetic gases 
 
2.4.5.Ozone Generator 
A VTTL 2 - Ozone Generator by OZOMAX Inc as shown in Fig 2.18 was used to generate ozone with 
compressed air set to a minimum flow rate of 6 cfm as a feed using the corona discharge method. The 
maximum setting was used to produce ozone and the concentration of ozone generated was measured 




1. T = 10-εbc= 10-A(where A is the absorbance at 254 nm)                                  ………...Equation 8 
2. Conc (molecules/cm3) = LN(T)/(absorption cross-section of ozone* b), where b = cell 
pathlength in cm                                                                                              ………...Equation 9 
 





2.4.6.Testing for Byproducts of UV-Photocatalysis 
The 18W UV lamp running the length of the reactor was fixed in the lamp holder. The walls of the 
reactor were lined with the TiO2 coated sheet. Five (5) µl of liquid Isoflurane was injected via the 
septum and allowed to volatilize. The peristaltic pump was used to ensure uniform concentration 
throughout the reactor. Once the concentration had stabilized, the UV lamp was switched on and the 
Isoflurane concentration was measured and analyzed. It was observed that the GC-FID did not show 
any new peaks during the degradation testing of Isoflurane and Sevoflurane other than the background 
noise as shown in Fig 2.19 and 2.20.  
 







Figure 2.20: Chromatograms depicting peaks observed before (left) and after (right) the Sevoflurane 
degradation 
 
The expected byproducts for the photocatalytic oxidation based on the literature review for Sevoflurane 
and Isoflurane are HF, HCl, CO2, Compound A (CF2=C(CF3)-O-CH2F), pentafluoropropanol. Of the 5 
compounds HF, HCl and CO2 cannot be detected by the GC-FID. Previous work hints at compound A 
might be a precipitate which again cannot be measured by GC. 109 Pentafluoropropanol is the only 
byproduct which is volatile and has C-H bonds, hence can be detected by the GC-FID however, since 
its sensitivity towards the FID isn’t known, no precise conclusions can be drawn about the after-
degradation peaks observed in Fig 2.19.  
Based on the literature review, a new procedure for testing any potential water soluble samples using 
Ion Chromatography was drafted. The major challenge with analyzing the samples directly was that 
they were gaseous in nature. Two different techniques were incorporated to collect the samples for 
anion testing specifically for the water-soluble HF and HCl using ion chromatography with a detection 
limit of 0.1 mg/l.   




30 ml DI using air as shown in Fig 2.21. The aim of the test was to capture the water-soluble 
degradation products from the reactor in the bubbler DI which could then be used for IC testing. It was 
required to keep the air flow rate to a minimum to ensure sufficient contact time and prevent the 
bubbler from over bubbling.  
 
Figure 2.21: Sample collection setup for testing of byproducts from photocatalysis of Isoflurane 
 
However, it was observed that the bubblers did not bubble at air flow rates below 6 L/min. The most 
probable reason for it being, leaks in the reactor probably at joints. For a reactor volume of 3.8 L it 
meant almost 40 seconds bubbling which was not sufficient for proper contact. Such high flow rates 
also compromised the bubbler capture efficiency. 
Theoretically, if all of the Isoflurane inside the reactor had degraded to HCl and all of it was captured 
then 1.48 mg of chlorides (as shown in the appendices) was expected in the bubbler sample. However, 
the IC results obtained for the bubbled sample estimated a total of 0.00063 mg of fluorides and 0.01 
mg of chlorides for the samples tested with the DI containing 0.00026 mg of fluorides and 0 mg of 




setup was not appropriate for sample collection since the high air flow rates into the bubbler reduced 
the capture efficiency of the bubbler and hence was abandoned. 
Second, before starting the experiment, the walls of the reactor were washed with DI and the wash 
water was collected in a vial for testing. When the UV experiment was complete and the Isoflurane 
had completely degraded, the UV lamp was switched on for an additional 30 min to encourage 
desorption of any gas adhered to the reactor walls. After 30 min, the lamp was switched off and the 
catalyst sheet was washed sufficiently using DI in an attempt to simply remove the top layer off the 
surface and, collect it in a plastic vial. The sheet was then removed, and the same procedure was 
performed with the reactor walls. A sample of the DI used for reactor wash was also collected to be 
tested as a blank. 
A major challenge observed with the catalyst surface wash water was that it was highly turbid due to 
the presence of TiO2 particles. It was filtered using various pore sized filter papers and syringe filters 
(0.25 to 0.45 µm). It was even centrifuged to see if the supernatant could be used for IC. However, it 
was confirmed that even the supernatant was highly turbid, and it could not be analyzed using IC. 
Hence the catalyst wash sample was disregarded. 
Hence, the reactor wall wash samples before and after the photocatalysis were only conducted to 
obtain a rough estimate of the possible byproducts from the UV-photocatalysis of Isoflurane and 
Sevoflurane. 
 
2.4.6.1.Safety Procedures while Experimenting with Isoflurane and Sevoflurane 




produces hydrogen fluoride or hydrogen chloride. This hydrogen fluoride or hydrogen chloride when 
in contact with water forms the respective acid. HF acid is highly corrosive and fuming in nature, 
although this is highly dependent on its concentrations. It is extremely harmful to the ocular tissues 
and concentrations as low as 5 ppm is known to cause eye irritations. It also acts as an irritant to the 
mucosa of the upper and lower respiratory tract and one of its most common toxicities is its ability to 
penetrate through the skin into bones and replace the calcium present with fluoride.81 
While capturing the anions with the bubbler setup, the theoretical mass of the maximum HF or HCl 
that may be produced if all of the reactant was to degrade (Sevoflurane/Isoflurane) was estimated. The 
amount of DI in the bubbler was altered to ensure that no more than 0.1% of the acid solution was 
being formed inside the bubbler to mitigate any risks while handling the bubbler. 
The below actions were taken before handling any possible HF/HCl (g) or HF/HCl (l) sources: 
1) Lab coat to cover the body 
2) Disposable gloves with nitrile gloves on top secured with tape to the lab coat sleeve to prevent 
any direct skin exposure  
3) Covered shoes to prevent harm during accidental spills 
4) All equipments (tongs, scissor, bubblers and connections) once used were neutralized with a 
10% NaHCO3solution overnight followed by a rinse with DI followed by tap water. 
5) The gloves once exposed to potential HF/HCl (g) or HF/HCl (l) were neutralized with a 10% 
NaHCO3solution followed by DI and final rinsed with tap water. 
6) The pH of the reactor wash sample was measured as soon as it was collected. 





To decontaminate any exposed surfaces: 
1) Once the reactor had been bubbled through or washed for sample collection, all the connections 
were removed and soaked in 10% NaHCO3 solution followed by a rinse with DI. 
2) The reactor was then de-assembled, and the non-electric ends and the body of the reactor were 
soaked in 10% NaHCO3 while the electric end of the reactor was wiped clean with a sponge 
soaked in 10% NaHCO3. 
3) The above cleaning was followed by tap water wash followed by a DI rinse. 
4) After cleaning, a fresh stream of air was passed through the reactor and sampled to ensure no 






3.RESULTS AND DISCUSSION 
3.1.Reproducibility 
In order to ensure the validity of the conclusions deduced from each experiment, all the experiments 
were conducted three times on different days with the same setup. To ensure reproducibility, all the 
experiments were conducted with the same sampling instruments. 
The error in the area counts as measured by the GC-FID when it was calibrated with 5 µl of Isoflurane 
is shown in Fig 3.1. 
 
 
Figure 3.1: The error in area counts as measured during calibration of Isoflurane 
 
The percentage error in the Isoflurane concentration when analysed at various times in the absence of 






Figure 3.2: The variation in concentration in the absence of any external factor as measured with 
Isoflurane at various times 
 
An error of 11 % (max) was observed at almost 17 min because, of the three trials done to study the 
wall effects of Isoflurane, in one trial the Isoflurane concentration fluctuated for almost 21 min after 
which it eventually decreased until the wall effects were saturated. Meanwhile for the other 2 trials the 
concentration had stabilized at almost 7 min after which it started to drop due to leaks. 
The error in the Isoflurane concentration measured in the presence of UV light as sampled from the 
reactor is shown in Fig 3.3. 
 




A maximum error of 2.1 % was observed in the Isoflurane concentrations during photolysis over the 
multiple runs. 
There were variations in the anesthetic gas concentrations measured throughout the sets of experiments 
even though efforts were made to try and keep the concentration as similar as possible. The variation in 
the anesthetic gas concentrations measured throughout the sets of experiment can be due to following 
reasons: 
1. Variation in the anesthetic injection volume – A 10µl GC auto sampler syringe was used to 
inject 0.5 µl of the liquid sample. Due to its small orifice there was often air bubbles pulled in 
along with the sample. Even though efforts were taken to remove every single air bubble during 
sampling, there were times when the air bubbles were difficult to remove hence, the volume of 
actual sample injected into the reactor was tested using the pullback method which was 
different with each experiment by almost 0.2 µl. In the pullback method the syringe was flushed 
with the sample several times to wet the barrel and plunger. The required volume of sample was 
then drawn into the syringe. The needle was removed from the sample and the plunger was 
pulled back to induce a pocket of air as a marker. The volume occupied by the air bubbles 
inside the syringe was subtracted from the total sample volume inside the syringe. The sample 
was then injected into the bulb and the plunger was pulled back to determine the remaining 
sample volume inside the syringe. The remaining sample volume was subtracted from the inlet 
sample volume measured to obtain the precise injected volume. 
2. The gas samples were taken using a Hamilton 500 µl GC gas tight syringe. Even though the 
samples when collected from the reactor were measured precisely, there were instances where 
carry-over occurred from injection to injection because the anesthetic gas from the previous 




could have been higher than what was being taken out of the reactor, although it is believed this 
was less than 10% and was generally more of an issue at low concentrations. To minimize this 
effect, after each injection the teflon plunger was placed near the FID heater to volatilize any 
anesthetic adhered to the plunger. 
3. The variation in the anesthetic gas concentration observed can be due to the injection method 
being followed during the experiments. The liquid anesthetic was injected via the septum on the 
top after which it is allowed to volatilize and circulated uniformly using the pump. This liquid 
falling inside the reactor might come in direct contact with either the reactor walls which were 
less absorbing or the more absorbing catalyst sheets which were lined against the reactor walls. 
Since the number of molecules of the catalyst at any point on catalyst sheet cannot be the same 
always, the extent of absorption of the liquid anesthetic entering the reactor by the catalyst 
molecules varied. 
4. With time the wall effects have the ability to passivate. Hence at the very beginning there might 
have been greater percentage of anesthetic loss to wall effects which over the continuous use of 
the reactor might have diminished due to saturation. 
5. Since it was a time-based experiment, the concentrations varied with change in time. Since not 
all samples for different experimental sets were taken at exactly the very same minute, changes 
in the resulting concentrations occurred. Therefore, the error for time and volume were 





3.2.Comparing the Efficiency of Three Advanced Oxidation Processes in Degrading 
the Anesthetic Gas 
Three advanced oxidation processes namely UV-photolysis, UV-ozonation and UV-photocatalysis 
were tested to determine their Halothane degradation efficiency.  
3.2.1.UV-Photolysis 
Five (5) µl of the liquid Halothane was injected into the reactor and allowed to volatilize. In the 
absence of any external factors the Halothane concentration was measured and analyzed in 500 µl 
volumes for a total time of 42 min until the wall effects were stabilized and constant leak rate was 
achieved. The 18 W UV light source was then switched on and 500 µl of the gas mixture from the 
reactor was sampled and the concentration of Halothane was measured using the GC as shown in Fig 
3.4. 
 
Figure 3.4: Change in the Halothane concentration with time in the absence and presence of UV light 
 
 








































Halothane was lost at a rate of ~ 9 ng/ml/min to leaks and wall effects. The decrease in the Halothane 
concentration was almost uniform at the start of the experiment but, eventually stabilized with time 
indicating stabilization of wall effects and constant leak rate. When the rate of decrease had dropped 
below 2 ng/ml/min, the light source was switched on. 
 
Figure 3.5: First order decay plot of Halothane concentration with time in the presence of  UV light 
 
 
The first order decay plot of Halothane in the presence of UV light was completely linear as shown in 
Fig 3.5. With 1400 ng/ml of Halothane, the rate of decrease of Halothane had increased to ~13 
ng/ml/min in the presence of UV light source. However, the decrease eventually stabilized at around 70 
min post irradiation. Overall, a 20% decrease during the dark reaction was recorded when compared to 
a 54% decrease in the presence of UV light over a time period of 40 min. 
This increase in degradation rate can be attributed to Halothane’s slight yet notable absorbance in the 
254 nm range. An attempt to measure the absorbance was made by injecting 5 µl of Halothane inside 




cuvette with air.  
The absorption cross section of Halothane decreases from 1.25x10-18 cm2/molecule at 204 nm to 
4.5x10-20 cm2/molecule at 254 nm.84 At 254 nm, an absorbance of 0.013 was recorded for 2280 ng/ml  
of Halothane with a 10 cm cuvette as shown in Fig 3.6. For the 1400 ng/ml of Halothane that was 
present inside the reactor before the UV light was turned on, an absorption fraction of 0.0045 was 
calculated (as shown in the Appendices). Hence with the 18W lamp which emitted 3.33x1022 photons 
in 70 min at 254 nm, only 1.5x1020 photons is expected to be absorbed by the Halothane based on the 
absorption fraction calculated. 
 
Figure 3.6: UV absorption spectrum 2280 ng/ml of Halothane measured in a 10 cm cuvette using the 
spectrophotometer 
 
The UV spectrum of Halothane obtained during the current work showed a maximum absorbance at 
around 204 nm after which the peak started to flatten. This UV spectrum obtained is similar to the ones 
found by other researchers in the region of 187 – 300 nm where Halothane was found to show a 
maximum absorbance at 204 nm and eventually reduced to a minimum at 290 nm.82,83 There was an 
additional absorbance peak observed at ~170 nm when the UV spectrum was measured between 160-

























Figure 3.7: Absorption cross section of Halothane at room temperature showing an absorbance peak at 




The Ozomax ozone generator was used as a source of ozone for the experiments. To measure the 
amount of ozone produced, the ozone was generated for approximately 10 minutes, then a sample of 
the ozone output was collected in a 10 cm UV cell and a UV spectrum of the ozone in the cell was 
recorded with the spectrophotometer. 
At 254 nm (the ozone peak centre), the absorption cross-section of ozone used was 1159x10-20 
cm2/molecule.85 Based on the absorbance obtained from the UV spectrum of ozone it was estimated 





Figure 3.8: UV absorption spectrum of ozone as measured in a 10 cm cuvette using the HP8452 
spectrophotometer 
 
The UV spectrum obtained from the experiments as shown in Fig 3.8 is in complete agreement with the 
ones obtained by other researchers.86 Ozone shows a maximum absorbance at 254 nm wavelength after 
which it starts to drop to almost 0 au at around 290 nm. 
The ozone generated was then flushed through the reactor to replace the air for 10 minutes then, the 
ozone generation was discontinued, and the reactor was closed. Halothane measuring 5µl was then 
injected into the reactor, allowed to volatilize and then a gas sample was collected. The concentration 
was allowed to stabilize till the rate of decrease in Halothane concentration dropped to 3 ng/ml/min. 
The 18W UV lamp was then switched on and the concentration decrease was monitored by periodically 


























Figure 3.9: Change in Halothane concentration in the presence of ozone followed by decrease in 
Halothane when subjected to ozone and  UV light 
 
 
During the dark ozonation in the presence of 2150.7 ng/ml of Halothane as shown in Fig 3.9, the 
decrease in the concentration was almost linear as evident from the R2 value. It was observed that no 
appreciable interaction occurred between Halothane and ozone in the absence of a light source. The 
loss in Halothane concentration was ~ 8.1 ng/ml/min in 50 min, which was almost equal the decrease 
observed in the case of dark reaction in photolysis (~ 8.9 ng/ml/min) as depicted in Fig 3.4. It can be 
concluded that this loss was primarily due to wall effects and leaks in the reactor. 
With 1705.8 ng/ml of Halothane, it was observed that the rate of decrease in the concentration after 
turning on the UV light was ~ 8.7 ng/ml/min in 60 min which was not much different from the rate of 
decrease in the absence of UV light (~ 8.1 ng/ml/min). The wall effects brought a reduction of 482 
ng/ml with 1773 ng/ml of Halothane, photolysis brought a reduction of 780 ng/ml with 1415 ng/ml of 
Halothane in 60 min as depicted in Fig 3.4, while UV-ozonation reduced 1705.8 ng/ml of Halothane by 




A possible reason for the slightly improved degradation efficiency of UV-photolysis in comparison to 
UV-ozonation may be due to the less efficient degradation of Halothane through OHo radical. The 
absorption cross-sections of Halothane and ozone at 254 nm are 4.24x10-20 and1.5x10-17 cm2/molecule 
respectively.84 With an almost 300 times greater absorbance area count, ozone absorbs more than 99% 
of the incident photons if present in equal amounts with Halothane. In this case 1163 ppm of ozone was 
present with only 30 ppm of Halothane hence, both halothane and ozone compete for the incident 
photons. Ozone may absorb more photons, but it appears not to really produce oxidizing agents, likely 
due to a lack of moisture inside the reactor. When irradiated with UV light, the ozone inside the reactor 
dissociates to form O2 and O atom which can either recombine or the nascent oxygen atom (O) might 
combine to produce O2 in the absence of moisture.  Hence, due to absorption of 99.99% of the incident 
photons by ozone, this combined with Halothane’s very low absorption coefficient leads to insufficient 
photons to produce a measurable change. 
The formation of oxidizing agents such as the hydroxyl radical (OHo) and superoxide radical (O2
o-) 
occurs when ozone is irradiated in the presence of water with the air. Since the compressed air used has 
only 11% humidity, this appears to have been insufficient to produce enough OHo radicals to introduce 
any change when compared to UV-photolysis. 
 
3.2.3.UV-Photocatalysis 
The UV-photocatalytic degradation efficiency of Halothane was tested using TiO2 catalyst. The reactor 
walls were lined with the catalyst coated support sheet and 5µl of the liquid anesthetic was injected into 
the reactor. The resultant gas was sampled in 500µl volumes from the reactor and analyzed until 




constant leak rate. Once the reduction rate had dropped below 3 ng/ml/min, the 18 W UV light was 
switched on and 500µl of the gas was sampled from the reactor and analyzed using the GC-FID until 
all the Halothane had been degraded as can be seen from the data in Figure 3.10. 
 
Figure 3.10: Change in the Halothane concentration with time due to wall effects, leaks and absorption 
on to the TiO2 surface followed by the change in concentration when subjected to UV-photocatalysis 
 
 
In the case of dark photocatalysis, the increase in the concentration reduction rate when compared to 
the dark reaction during photolysis was due to a combination of wall effects, leaks and absorption on to 
the TiO2 surface. A concentration of 562 ng/ml of Halothane from a total concentration of 1810.7 ng/ml 
was lost during the dark photocatalysis when compared to a loss of 362 ng/ml during the dark reaction 
in photolysis.  The decrease in Halothane concentration in the case of UV-photocatalysis was not linear 
as can be seen from Figure 3.10. The photocatalysis of the anesthetic gas was assumed to be apparently 




in the presence of UV light. With a starting concentration of 1295.7 ng/ml, the rate of decrease was 125 
ng Halothane/ml/min within the 1st 10 min of UV irradiation, which accounted for 93% of the total 
Halothane degradation. The rate of decrease then dropped to ~8 ng/ml/min for the next 10 min 
probably due to the limited availability of the reactant or reduced activity of the catalyst surface and 
finally stabilized to around 0.2 ng/ml/min for the remaining duration of the experiment. 
 




Fig 3.11 compares the Halothane degradation efficiency of the three AOPs over 20 min. UV-
photocatalysis achieved ~99.9% Halothane degradation compared to a degradation of ~ 35% for both 
UV-ozonation and UV-photolysis. The presence of the catalyst improved the degradation efficiency 
since in the presence of UV light, TiO2 acts to produce hydroxyl radicals which accelerate the 
anesthetic degradation.  





































likely due to the scavenging of most of the light by ozone owing to its greater absorption cross-section 
and higher concentration than that of halothane.  
To establish if this same phenomenon would occur with Isoflurane and Sevoflurane, the UV absorption 
spectrum was recorded as was done with Halothane. The recorded UV spectrum for Isoflurane and 
Sevoflurane is shown in Fig 3.12 and 3.13. 
 
Figure 3.12: UV absorption spectrum of 1200 ng/ml of Isoflurane 
 
The UV absorption spectrum recorded for Isoflurane showed a maximum absorbance at ~ 200 nm as 
shown in Figure 3.12 with an absorption cross section of 2.61x10-21 cm2/molecule.84 A similar 


























Figure 3.13: UV absorption spectrum of 1567 ng/ml of Sevoflurane 
 
 
Unlike the UV absorption spectrum obtained by other researchers which suggest that Sevoflurane does 
not absorb in the UV region83, the UV spectrum obtained in the current research as shown in Fig 3.13 
depicts a similar absorbance pattern for Sevoflurane with an absorption cross section of 1.331x10-20 
cm2/molecule.84 The theoretical absorption cross sections for these two anesthetic gases were 
compared with ozone. Since their absorption cross-sections were smaller in magnitude than Halothane 
(2.6x10-21 and 1x10-20 respectively),84 their behaviour when subjected to ozonation was presumed to be 
similar if not lower than Halothane. Hence, further tests with these gases were carried out only using 
UV-photolysis and UV-photocatalysis. 
 
Once UV-photocatalysis was determined to be the preferred degradation technique among the ones 

























3.3.Effect of the Type of Photocatalyst Used on the Anesthetic Gas Degradation 
Rate 
The efficiency of ZnO and TiO2as a photocatalyst in degrading Halothane and Sevoflurane was 
compared in this experiment.  
The reactor walls were lined with the catalyst coated support sheet and 5µl of the anesthetic liquid was 
injected into the reactor and allowed to volatilize. The contents of the reactor were mixed using the 
peristaltic pump. The resultant gas was sampled until equilibrium was reached, indicating no further 
absorption onto the catalyst surface and a constant leak rate. The 18 W light source was then switched 
on and, 500µl of the gas was sampled at intervals over 20 min and analyzed using the GC-FID as 
depicted in Fig 3.14 and Fig 3.15. 
 
Figure 3.14: Change in the Halothane concentration when subjected to UV-photocatalysis the presence 
















































Figure3.15: Change in the Sevoflurane concentration when subjected to UV-photocatalysis the 
presence of TiO2 and ZnO 
 
 
The experiments clearly indicated that TiO2 was more efficient in oxidizing both Halothane and 
Sevoflurane in the presence of UV light than ZnO where the rate of decrease was rather insignificant. 
During the dark photocatalysis, in the presence of TiO2 and ZnO, both Halothane with an initial 
concentration of 1111.4 ng/ml (33.5% and 26.2%) and Sevoflurane with an initial concentration of 553 
ng/ml (22.2% and 20%) absorbed almost equally on the respective catalyst surfaces. This suggested 
that they had almost a similar affinity to the catalysts tested.  
The degradation rate in the case of Sevoflurane and Halothane with ZnO and UV was insignificant. 
This suggested that both Halothane and Sevoflurane did not degrade significantly with ZnO as a 
photocatalyst. 















































drastic, with a loss of 1100 ng/ml in the first 10 min of irradiation accounting for a 98.7 % loss of 
Halothane. Due to the depletion of the reactant (~13 ng/ml) or accumulation of byproducts or reaction 
intermediates on the catalyst surface the rate of reaction slowed down to 2.8 ng/ml/min afterwards. A 
similar trend was observed in the case of 553 ng/ml of Sevoflurane with a loss of almost 500 ng/ml in 
the first 10 min of irradiation. This decrease however stabilized after 10 min by which time 98.9% of 
the Sevoflurane had already degraded. 
 
Figure 3.16: UV/Vis absorbance spectrum of TiO2, ZnO and TiO2/ZnO.
87 
 
Even though TiO2 and ZnO have almost similar band gaps of 3.33 and 3.26 eV respectively, the UV-
Vis absorbance spectrum of TiO2 and ZnO films clearly shows that TiO2 has a much larger absorbance 
than ZnO at 254 nm as shown in Fig 3.1687. Since the reference does not talk about the individual 
concentrations or the path length of the cell while measuring the UV spectrum of ZnO and TiO2, we 
presume that the UV spectrum recorded for ZnO and TiO2 in Fig 3.14 was carried out in the same UV 




of ZnO with the incident light at 254 nm due to its lower absorption cross section thus limiting the 
production of OHo radicals. This possibly is the reasons for the limited anesthetic degradation rate of 
ZnO. The difference in the form of catalyst particles used: TiO2 in the form of nanopowder and ZnO in 
plain powder form can also possibly influence the amount of catalyst surface area available during UV-
photocatalysis. 
Experiments conducted with ZnO and TiO2 by other researchers on photocatalysis of selective 
impurities in water have given similar results as obtained in this experiment.88-91 TiO2 had shown 
greater degradation efficiency in the UVC region when compared to ZnO. TiO2 was found more 
efficient in the acidic environment while ZnO was efficient in the alkaline region for the removal of 
poly vinyl chloride from aqueous solutions.88 ZnO nanopowder was less efficient in degrading textile 
wastewater when compared to TiO2 at 254 nm due to its lesser purity.
89 ZnO was observed to be more 
efficient in degrading estrone from wastewater than TiO2 only in the UVA region (315-400 nm), while 
in the UVC (100-280 nm) region TiO2 was more efficient in degrading estrone present in water 
(compound often used in treating the membranes after being used for reverse osmosis) than ZnO. This 
change in efficiency can be possibly attributed to ZnO’s greater absorbance than TiO2 in the UVA 
region.90 
 
3.4.Influence of the Incident Light Source Wavelength on the Anesthetic Gas 
Degradation Rate 
Illumination was provided by a 9W 254 nm and a 365 nm UV lamp for comparing the effect of 
different UV wavelengths on the anesthetic gas degradation rate. This setup was used in the absence of 




aluminum sheet for photocatalysis as shown in Figure 3.18. 
 
Figure 3.17:Influence of the incident light wavelength on the Halothane degradation rate in the absence 
of the photocatalyst 
 
 
In the absence of any UV irradiation, the rate of degradation of 1300 ng/ml of Halothane due to wall 
effects and leaks was ~ 7.5 ng/ml/min. With  1368.9 ng/ml of Halothane, in the presence of the 365 nm 
light source, the degradation rate slightly increased to ~ 8.3 ng/ml/min. However, in the case of the 254 
nm light source with the same Halothane concentration, ~ 12 ng/ml/min of decrease was observed. In 
the time of 30 min for which each of these experiments was conducted, 225 ng/ml of Halothane was 
lost due to leaks, 249 ng/ml was lost due to leaks and photolysis with the 365 nm UV light source and 
360 ng/ml was lost due to leaks and photolysis with the 254 nm light bulb. An overall decrease of 
12.3% and 27% was observed during the photolysis of 1368.9 ng/ml of Halothane in the presence of 
365 nm light source and 254 nm light source respectively in 30 min. 
















































5.50x1018 photons/sec. The absorption cross section of Halothane decreases from 4.5x10-20 
cm2/molecule at 254 nm to <1.20x10-23 cm2/molecule (approximately) at 365 nm.84 Hence with these 
absorption cross sections in 30 min at 254 nm, 1.58x1019 molecules of Halothane will absorb 3.04x1019 
photons and at 365 nm Halothane will absorb 1.17x1016 photons (as shown in the appendices). Since 
much lower photons are absorbed by Halothane at 365 nm than at 254 nm, UV photolysis at 254 nm 
was much more profound than at 365 nm. 
 
To test the influence of the incident light wavelength on UV-photocatalysis of Halothane, the reactor 
wall was lined with the TiO2 coated aluminum sheet. Five (5) µl of the liquid Halothane was injected 
into the reactor, allowed to volatilize and then sampled till stabilization. Once the Halothane 
concentration was found to be stable, the light source was switched on to test the degradation efficiency 
as plotted in Figure 3.18. 
 
Figure 3.18: Change in the Halothane concentration with time when subjected to photocatalysis with 
two different incident light wavelengths 
y = -0.002x + 7.3182
R² = 0.8657













































In the presence of 1511 ng/ml of Halothane, with the 365 nm light source, the change in Halothane 
concentration with time was negligible during photocatalysis with a decrease of 3% in 20 min. The 1st 
order decay curve plotted in Fig 3.18 is almost a linear fit in the case of UV-photocatalysis with 254 
nm light source with a reaction rate coefficient of 0.1 min-1 indicating that the rate of reaction is 
dependent purely on the reactant concentration. Just like in the other experiments conducted above, the 
rate of degradation was extremely high in the first 10 min with a loss of 111.1 ng/ml/min of Halothane 
accounting for 74% of the total degradation. A total degradation of 85% was recorded during 
photocatalysis with the 254 nm light source. 
The 9W 254 nm light source produces 3.83x1018 photons/sec while the 365 nm lamp produces 
5.50x1018 photons/sec. According to the UV spectrum in Fig 3.16 the absorbance of TiO2 at 254 nm is 
almost three times the absorbance at 365 nm. Hence TiO2 will probably absorb 99% more photons at 
254 nm than at 365 nm thereby, producing more OHo radicals which will accelerate the photocatalysis 
of Halothane. The greater absorbance of TiO2 at 254 nm coupled with the relatively greater absorption 
cross section of Halothane at 254 nm when compared to 365 nm possibly contribute to the greater 
photocatalytic degradation rate of Halothane at 254 nm when compared to 365 nm. 
 
3.5.Influence of the Power of the Light Source on the Anesthetic Degradation Rate 
From the results obtained in Section 3.4, it was evident that the light source output at 254 nm was more 
efficient in degrading Halothane. The next step was to determine the influence of the power of the light 
source on the anesthetic degradation rate by comparing the results for the 9W and 18W lamps. 




Halothane had volatilized and the concentration had stabilized the UV light source was switched on for 
30 min to monitor the decrease in the Halothane concentration. 
The influence of the power of the UV bulb was also tested using photocatalysis. The photoreactor was 
once again flushed with the compressed air. The reactor walls were lined with the same amount of TiO2 
for both the light sources. Five µl of Halothane was injected into the reactor, allowed to volatilize and 
the peristaltic pump was switched on to ensure uniform mixing within the reactor. Once the Halothane 
concentration was found to be stable, the UV light source was switched on to monitor the decrease in 
the Halothane concentration. Figure 3.19 compares the Halothane degradation efficiency of the 9 W 
light source with a length of 210 mm against the 18W UV light source with a length of 325 mm in 
terms of photolysis and photocatalysis. 
 
Figure 3.19: 1st order decay plot of Halothane under the influence of 9W and 18W UV light source 
 
The 1st order decay plot of Halothane is not perfectly linear in all the four cases as observed from their 




lamp and a loss of 19 ng/ml/min with the 9W UV lamp were recorded with a degradation of 45% and 
27% respectively in 30 min. For the photocatalysis of 2224.6 ng/ml of Halothane, a loss of 110.4 
ng/ml/min in 20 min with the 18W UV lamp and a loss of 95.4 ng/ml/min in 20 min with the 9W UV 
lamp was recorded. A total degradation of 87% and 99.8% was achieved, when subjected to 
photocatalysis with the 18W and the 9W lamp respectively in 30 min. 
For the duration of the experiment, the 18W lamp emitted 1.38x1022 photons while the 9W lamp 
emitted 6.89x1021 photons assuming 33.3% of the supplied energy was converted into light. The 
photoreactor contained 2.59x1019 molecules of Halothane, hence based on the absorption cross section 
of Halothane, with the 18W lamp 9.86x1019 photons will be absorbed by the 2224.6 ng/ml of 
Halothane and with the 9W lamp the same amount of Halothane will absorb 4.92x1019 photons 
Assuming quantum yield=1, the measured absorption spectrum of Halothane was accurate, the 
conversion in the lamp is accurately 33.3% and the absorption characteristics of the anesthetic do not 
vary once inside the reactor, a complete degradation of Halothane during photolysis with the 9W lamp 
is expected since, the amount of photons absorbed by the Halothane in the presence of the 9W lamp 
source is greater than the total number of Halothane molecules present inside the reactor. In such a 
scenario, Halothane acts as a limiting agent and the excess photons produced and absorbed in the 
presence of the 18 W lamp source do not add much value. However, this is not in accordance to what 
was observed during the photolysis experiment since, at the end of 30 min unreacted Halothane was 
observed inside the reactor. Hence one or more of the assumptions are incorrect. The excess photons 
generated by the 18 W lamp could potentially interact with more Halothane to cause a greater 
photodegradation during photolysis if there were a lot more halothane molecules to interact with. 
In the case of photocatalysis, the catalyst sheet has 3.4x1022 molecules of TiO2, these excess electron 




further generate OHo radicals that increase the degradation rate of Halothane. Another probable reason 
for increased degradation is the varying length of the 2 light sources used. Since the 18W lamp ran the 
length of the reactor, the entire catalyst sheet was illuminated by the incident photons and hence 
participated in the degradation, however, the 9W lamp barely covered 70% of the catalyst sheet hence 
the contribution of the remaining 30% of the catalyst sheet in the degradation would have been limited. 
The reaction rate coefficients in case of photolysis with the 9W and the 18W UV light source were 0.01 
min-1 and 0.02 min-1 respectively. In the case of photocatalysis, the reaction rate constant initially 
started with 0.13 min-1and 0.26 min-1 with the 9W and 18W lamp, however, in the next 30 min the 
reaction rate dropped by 46 % and 30% to 0.07 min-1 and 0.18 min-1 respectively. 
Even though no reaction intermediates were detected on the GC during the photocatalysis, a possible 
buildup of by products or reaction intermediates such as HF, HCl and HBr on the photocatalyst can 
reduce the degradation rate. In the case of the 9W UV lamp, the reactor still had sufficient Halothane to 
be degraded after 30 min of treatment, hence catalyst poisoning, deactivation or lack of oxidizing 
radicals due to reduced photon generation is a probable reason for the drop in the reaction rate constant.  
Literature suggests similar results were obtained with degrading Eosin Y (stain used in histological 
studies) in water, where the rate of degradation dropped from 93 to 82 % when the lamp power was 
reduced from 16 W to 6 W with ZnO as a photocatalyst.92 Review also suggests that the single pass 
removal efficiency of Isoflurane increased consistently with an increase in the light intensity from 1 – 4 






Figure 3.20: Variation of reaction rate with time for Halothane in the presence of 18W UV lamp  
 
The instantaneous reaction rate constants for the photocatalysis of Halothane decreased with time as 
shown in Fig 3.20. This suggests that OHo radicals are the primary contributors in the oxidation of 
Halothane. However, no literature is currently available to obtain a deeper insight into the Halothane 
chemistry. 
The above studies have clearly shown that UV-photocatalysis with TiO2 and an 18W 254 nm UV lamp 
was a more effective technique among the ones tested to degrade the anesthetic gases being emitted 
from the health care facilities directly into the environment. 
3.6.To Test the Influence of Catalyst Area Illuminated on the Anesthetic Gas 
Degradation Rate 
Since the 18W UV lamp source ran the entire length of the reactor, the relatively smaller 9W UV lamp 
with a length of 210 mm was used to test the influence of the catalyst surface area illuminated on the 






































catalyst sites not receiving the emitted photons, thus preventing them from participating in the 
photocatalysis, the test described below was performed. 
Two media containing equal amounts of TiO2 catalyst, one extending to the length of the UV lamp (21 
cm x 25 cm) and the other extending to the length of the reactor (30 cm x 25 cm) were fabricated. 
These catalyst coated sheets were lined against the reactor walls. Five (5) µl of Halothane were injected 
via the inlet septum and allowed to volatilize. After the concentration had stabilized, the UV lamp was 
turned on. The resulting gas concentrations measured using the GC is presented in Fig 3.21. 
 
Figure 3.21: First order decay plot of Halothane under the influence of varied catalyst illuminated area 
 
 
The first order decay plot of Halothane in the presence of 2 different illuminated catalyst surface area 
was not completely linear, as evident from their R2 values. In both the cases, with an initial 
concentration of 2224.6 ng/ml, the maximum loss of Halothane occurred in the first 10 min of the 
illumination. In the case of the full-length catalyst sheet, Halothane was lost at a rate of 163.7 
ng/ml/min, while in the case of the half catalyst sheet it was lost at a rate of 136.7 ng/ml/min in the first 




reduced catalyst activity. An overall decrease of 85.12% and 86.7% was observed during the 
photocatalysis in the presence of the half and the full catalyst sheet respectively. The reaction rate 
constants for the first 10 min in both the cases were 0.095 and 0.13 min-1respectively. 
It was evident that the possibility of a part of the catalyst sheet not being activated due to lack of 
incident light could be ruled out as a significant factor in influencing the anesthetic degradation rate 
when the power of the light source was varied.  
 
3.7.The Influence of Type of Catalyst Support Surface on the Anesthetic Gas 
Degradation Rate 
The three different support surfaces (fiberglass mesh, flat aluminum sheet, fiberglass mesh supported 
on aluminum sheet) were coated with a same amount of aqueous mixture of powdered TiO2 (0.17 g 
TiO2/ml H2O) and dried overnight in ambient air. The reactor walls were lined with the full flat 
aluminum sheet or the aluminum sheet supporting the fiberglass mesh. The third catalyst test support 
surface namely the fiberglass mesh was supported on the light source using closure seals by wrapping it 
three times around the light source. This was done to ensure that the TiO2 molecules came in sufficient 
contact with the photons being generated from the light source first for the formation of electron hole 
pairs. 
The photocatalytic degradation was tested with 5 µl of halothane and the 9W 254 nm light source. The 





Figure 3.22: Concentration vs time profile during the photocatalysis of halothane in the presence of 
various support surfaces 
 
In the absence of a light source, the loss in the Halothane concentration over 20 min in the presence of 
the three support surfaces due to wall effects, leaks and absorption on to the catalyst surface was almost 
approximately 13% for all when compared to a 9.4 % loss due to the wall effects and leaks alone. 
In the presence of 1297.5 ng/ml of Halothane, the TiO2 coated on the fiberglass mesh degraded 24% of 
the Halothane in 35 min. The rate of decrease in the first 10 min of the photocatalysis was 20.5 
ng/ml/min which reduced to 10.9 ng/ml/min in the next 8 min, and finally dropped to 0.5 ng/ml/min 
over the final 17 min. 
In the presence of 1288 ng/ml of Halothane, the TiO2 coated on fiberglass cloth supported on the 
aluminum sheet degraded 80% of the Halothane in 35 min. In the first 10 min of the photocatalysis, the 
rate of decrease was 68.8 ng/ml/min followed by a drop to 21.2 ng/ml/min in the next 8 min and finally 



















































In the presence of 1297.5 ng/ml of Halothane, the TiO2 coated on the aluminum sheet support degraded 
99.9% of the Halothane in 35 min. The degradation started with loss of 105 ng/ml/min in the first 10 
min. The rate then slowed down to 15.15 ng/ml/min in the next 8 min. 
In summary the fiberglass mesh alone degraded Halothane by 24% in comparison to the 80% 
degradation by the fiberglass mesh fixed on the aluminum sheet and 99.6% by the aluminum sheet 
alone in 35 min. 
The primary reason for the difference in degradation rate was due to the structure of the support 
surface. Since the fiber glass cloth was highly porous, depositing the required amount of catalyst onto 
the surface became highly challenging, requiring multiple coats of the catalyst suspension. This 
combined with the setup where the fiberglass mesh was wrapped thrice over the UV lamp reduced the 
number of TiO2 molecules that came in direct contact with the emitted photons and the Halothane. The 
catalyst layer closest to the UV lamp would have formed the OHo radicals however, the OHo radicals 
would have to travel through the other two layers to be able to come in contact with the Halothane. On 
the other hand, the outermost catalyst layer in contact with the Halothane will not be in a position to 
generate the required amount of hydroxyl radicals since the incident photons being emitted from the 
light source will need to travel through the other layers thus limiting its degradation efficiency when 
compared to the fiberglass mesh supported on the aluminum sheet or the aluminum sheet alone. 
The difference in the degradation rate between the fiberglass mesh supported on the aluminum sheet 
and the aluminum sheet by itself is probably due to the fibrous nature of the fiberglass cloth. Due to its 
nature, there are high chances that the catalyst water suspension while being coated on the fiberglass 
mesh supported on the aluminum sheet was absorbed into the inner layers of the mesh. Since 




the surface generated hydroxyl radicals in order to degrade. Due to the absorption of the catalyst, even 
though the required change in the dry weight was observed during catalyst deposition not all of the 
TiO2 molecules were available on the surface of the mesh to absorb the incident photons and generate 
the expected amount of hydroxyl radicals. In the case of the aluminum sheet by itself, since no such 
inner layer absorption of the catalyst molecules into the sheet was possible, all the deposited TiO2 
molecules were available on the surface of the catalyst support to produce the expected amount of 
hydroxyl radicals. The nature of the catalyst support surface namely polished or rough can also 
influence the actual catalyst surface area available for interaction with the anesthetic gas molecules. 
For the following experiments, flat aluminum sheet was used as the catalyst support surface unless 
otherwise mentioned. 
 
3.8.The Influence of the Amount of Catalyst Used on the Anesthetic Gas 
Degradation Rate 
Support surfaces fabricated with consecutive coats of various amounts of TiO2 catalyst on the 
aluminum sheet were lined against the reactor walls. Five (5) µl of Halothane was injected into the inlet 
septum and allowed to volatize. After the concentration was found to stabilize, the 18 W 254 nm UV 





Figure 3.23:Variation in the Halothane concentration with change in the catalyst loading 
 
It can be concluded from the results that an increase in the catalyst loading resulted in an increase in the 
Halothane degradation rate up to a specific amount. Beyond that specific amount, there was a range of 
catalyst loading where the degradation rate remained the same. Any further increase in the catalyst 
loading beyond this range reduced the Halothane degradation rate. This was in complete agreement 
with the observations found in the literature.93-98 
It was observed from the experimental results that in the presence of 1052.3 ng/ml of Halothane, the 
catalyst loading  of 0.07 g/m2 degraded Halothane at the rate of 35.19 ng/ml/min in the first 20 min of 
the irradiation. However, with the same initial Halothane concentration, the catalyst loading of 0.59 
g/m2 degraded Halothane at the rate of 54.3 ng/ml/min and the catalyst loading of 1.2 g/m2 degraded 
Halothane at the rate of 51.8 ng/ml/min in the first 20 min of the irradiation. In 30 min of the 
irradiation, 84%, 99.8% and 96% of the initial Halothane had been degraded by the three different 
















































Increasing the TiO2 loading increased the number of active sites available, which increased the amount 
of hydroxyl radicals produced. For a fixed Halothane inlet concentration, only a fixed amount of 
catalyst sites will be occupied. The reactor contained 2.59x1019 molecules of Halothane. A catalyst 
loading of 0.07 g/m2 contained 3.77x1021 molecules of TiO2, the catalyst loading of 0.59g/m
2 contained 
3.32x1022 molecules of TiO2 and the catalyst loading of 1.2 g/m
2 contained 6.86x1022 molecules of 
TiO2. As mentioned before, UV-photocatalysis is a surface reaction however all the catalyst sheets used 
in this experiment were fabricated with consecutive coats meaning not all of the deposited TiO2 
particles were available on the surface of the catalyst sheet to absorb the incident photons. The catalyst 
loading of 0.59 g/m2 degraded more of the Halothane when compared to the catalyst loading of 0.07 
g/m2 probably due to presence of greater number of surface TiO2 molecules. When the loading was 
increased beyond 0.59 g/m2, the excess catalyst active sites either remained unoccupied or the support 
was so heavily loaded that it led to agglomeration of catalyst particles which limited the amount of 




3.9.The Effect of Anesthetic Gas Inlet Concentration on Its Degradation Rate 
The most efficient catalyst loading of 0.59g TiO2/m
2 on the same aluminum support surface was used 
to in order to test the change in anesthetic gas degradation rate with change in its inlet concentration. 
The catalyst sheet was prepared as previously mentioned. The reactor was flushed with compressed air 
and the walls were lined with the photocatalyst medium. Four different volumes of Halothane (5 µl, 




connected to the ends of the reactor was switched on to continuously mix the contents inside the 
reactor. Once the inlet concentration had stabilized, the 18W UV light source was switched on and the 
decrease in Halothane concentration was measured by analyzing 500 µl samples using the GC as 
plotted in Fig 3.24. 
 
Figure 3.24: Degradation profile of Halothane at various normalized inlet concentrations 
 
 
It was clearly evident that the catalyst loading used in the experiment was efficient in degrading 
Halothane at various inlet concentrations, but the degradation efficiency reduced with increase in the 
inlet concentration. Our results are similar to those reported in literature as examples state that the 
photocatalytic degradation rate of methylene blue dropped from 87 to 40% as the initial concentration 
was increased from 25 to 100 mg/l in the presence of ZnO as the photocatalyst.92 Similarly, it was 
observed that during the degradation of toluene in the presence of TiO2, with the increase in 
concentration from 20 to 100 ppm the removal efficiency dropped from 37 % to 27%.99 
In the presence of 0.59 g TiO2/m


























in 30 min was observed with 5 µl, 10µl, 15 µl, 25 µl of Halothane respectively. With 5 µl of Halothane 
a degradation rate of 105.13 ng/ml/min was observed in the first 10 min of the irradiation. For the same 
time a degradation rate of 76.83 ng/ml/min, 65.34 ng/ml/min and 65.1 ng/ml/min was observed with 
10µl, 15 µl, 25 µl of Halothane respectively. In case of the higher volumes (10 µl, 15 µl, 25 µl), the 
degradation rate eventually stabilized after 50 min suggesting that no more oxidizing radicals were 
available to degrade the Halothane molecules.  
The injected volumes of 5 µl, 10µl, 15 µl, 25 µl correspond to 2.86x1019, 5.72x1019, 8.58x1019 and 
1.43x1020 molecules of Halothane respectively. The catalyst loading of 0.59g/m2 contained 3.32x1022 
molecules of TiO2. Even though the number of molecules of TiO2 on the whole is much higher than the 
number of molecules of Halothane, the number of surface TiO2 molecules varies widely since each 
catalyst sheet was prepared with successive coats to achieve the required loading. Hence, with the 
change in number of surface TiO2 molecules the number of hydroxyl radicals generated will also 
change thus, affecting the Halothane degradation rate. Another possible reason for decrease in 
degradation is increased absorption of incident photons at higher reactant volumes, which reduced the 
number of photons available for the catalyst molecules to generate hydroxyl radicals.   
During the experiment it was observed that for higher inlet volumes like 15 µl and 25 µl, reactant 
concentrations were not stable during the experiments to be measured accurately. This can be attributed 
to the method of injection used throughout this work. At greater volumes say 15 µl or 25 µl, more 
liquid anesthetic absorbs directly on to either the catalyst sheet or the reactor walls when injected via 
the septum. With the contents of the reactor being continuously mixed using the pump, some of this 
absorbed anesthetic comes off at different times causing an unexpected increase in the anesthetic gas 
concentration when measured using the GC. However, this effect is not profound at lower anesthetic 




Considering all the above factors, the catalyst loading of 0.59g TiO2/m
2 was considered to be 
appropriate to achieve maximum degradation for lower Halothane concentrations. 
 
3.10.The Effect of Moisture on the Anesthetic Gas Degradation Rate 
To test the influence of moisture, standard room air with an estimated 30% relative humidity based on 
the humidity in the lab was used instead of the usual compressed air which had a low relative humidity 
level of 11%. The catalyst sheet was prepared as previously mentioned. The reactor was flushed with 
room air by leaving one end of the peristaltic pump tube open outside the fumehood and into the room 
in a such way that the room air was pulled in and circulated through the reactor when the peristaltic 
pump was switched on. Once the reactor had been flushed with sufficient room air, the reactor was 
closed and, the reactor walls were lined with the catalyst sheet. The desired volume of Halothane (5 µl) 
was injected via the septum and allowed to volatilize. The peristaltic pump was connected to both the 
ends of the reactor and was switched on with a flow rate of 500 ml/min to mix the gases inside the 
reactor. Once the inlet concentration had stabilized, the 18 W 254 nm UV light source was switched on 
and the decrease in the Halothane concentration was measured by analyzing 500 µl samples using the 





Figure 3.25: Time concentration profile of Halothane in the presence of catalyst and moisture 
 
 
With an initial concentration of 1852.8 ng/ml of halothane, the rate of decrease of Halothane due to 
absorption and wall effects increased from 16.3 ng/ml/min to 20.8 ng/ml/min in 20 min when the 
reactor was flushed with moist air. When the same concentration of Halothane was subjected to UV-
photocatalysis, an insignificant increase in the degradation rate from 91.7 ng/ml/min to 92.01 
ng/ml/min in the first 20 min of irradiation was measured, when the compressed tank air was replaced 
with the moist air.  
There are conflicting results reported with effect of moisture on the degradation rate. Selective 
literature with other pollutants observes an increase in the rate of degradation of the reactant with 
increase in the moisture content up to a limit. Any further increase in the moisture content reduces the 
degradation rate.100-102  For example, the degradation rate of toluene increased with increase in humidity 
up to 35% due to formation of additional hydroxyl radicals, however, the rate decreased for any further 
increase in humidity due to competitive catalytic adsorption.103 On the contrary, the degradation rate of 










































104 Similarly, the single pass removal efficiency of Isoflurane decreased with 
increase in the relative humidity from 20 – 80 % with an inlet concentration of 0.5 ppm, I=4.5 mW.cm-
2 in a closed loop multi pass photoreactor equipped with TiO2.
75 
Introducing moisture not only increases the hydroxyl ion concentration but also suppresses the electron 
hole combination.105 However, increased moisture content acts as a competitor for adsorption on to the 
catalyst surface thus limiting the degradation efficiency. 
Since the catalyst medium was coated with a suspension of 5 gm of TiO2 in 30 ml DI, it already had 
1x1024 molecules of water. After the overnight drying, even if 99% of the water molecules had 
evaporated, the sheet would have still had sufficient water molecules to interact with all of the available 
TiO2 to produce 10
22 hydroxyl radicals which will then completely oxidize all of the 2.59x1019 
molecules of Halothane present inside the reactor. The catalyst medium was self-sufficient in the 
required water molecules hence, any further addition of moisture either via the air stream or the catalyst 
media would have probably not increased the degradation rate significantly. 
 
3.11.UV-Photocatalysis of Isoflurane 
The study with Halothane clearly proved that UV-photocatalysis with TiO2 at 254 nm was the most 
promising advanced oxidation process for breaking down the waste anesthetic gases being released into 
the environment as compared to the other processes tested. 
The 18W 254 nm UV lamp running the length of the reactor was fixed in the lamp holder. The walls of 
the reactor were lined with the catalyst coated aluminum sheet. Five (5) µl of the liquid Isoflurane was 




contents of the reactor. Once the concentration had stabilized, the UV lamp was switched on and the 
Isoflurane concentration was measured. The results are presented in Fig 3.26. 
 
Figure 3.26: First order decay plot of Isoflurane when subjected to UV-photocatalysis 
As can be observed in Fig 3.26, at an initial concentration of 911 ng/ml, 99.8% of the Isoflurane had 
degraded in 20 min with a degradation rate of 87.6 ng/ml/min in the first 10 min of the irradiation and a 
degradation rate of 3 ng/ml/min over the remaining 10 min of the reaction.  
 
Figure 3.27: Change in the instantaneous reaction rate constants and the Isoflurane concentration when 







































































It could be concluded that degradation of Isoflurane proceeds in 3 phases, at the beginning the 
instantaneous reaction rate constant is low (0.091 min-1), with time it increases and achieves a 
maximum (0.35 min-1) and then finally the instantaneous reaction rate trends downward with time (0.29 
min-1) as shown in Fig 3.27. However, the instantaneous reaction rates during the UV-photocatalysis of 
Halothane as shown in Fig 3.20 trended downwards with time from the beginning of the UV 
irradiation. A probable reason for this difference can be attributed to the limited number of halogens in 
Halothane (C2HBrClF3) when compared to Isoflurane (C3H2ClF5O) which may contribute to a different 
molecular structure, which can influence the halogen abstraction by the hydroxyl radicals during UV-
photocatalysis. 
The process of degradation begins with generation of OHo radicals from the TiO2 surface due to 
formation of electron-hole pairs. With the passage of time, the instantaneous reaction rate constants 
increase suggesting a faster degradation of Isoflurane which is possible if additional oxidizing agents 
have been produced. The attack of OHo radicals on Isoflurane generates Clo radicals which further 
initiate a chain degradation reaction. With time, the instantaneous reaction rate constant starts to drop 
probably due to depleting reactant concentration or inactivity of the catalyst resulting from the 
accumulation of reaction intermediates or by-products on to the catalyst surface.  
This unique chain degradation mechanism has been studied in literature extensively for 
trichloroethylene (TCE)106,107 and perchloroethylene92,94. It was agreed that TCE undergoes a chain 
degradation mechanism in the presence of OHo and Clo radicals.95-97 Literature also points out a similar 






3.11.1.Testing for Byproducts of Photocatalysis of Isoflurane 
Before starting the experiment, the walls of the reactor were washed with DI and the wash water was 
collected in a vial for testing. Once Isoflurane had completely degraded, the UV lamp was switched on 
for 30 min to encourage release of any contaminants adhered to the reactor walls. After 30 min, the 
lamp was switched off and the reactor was opened. The catalyst sheet was removed, the walls of the 
reactor were washed with DI and, the wash water was collected in a vial and tested for their chlorine 
and fluorine ion concentration using ion chromatography. A sample of the DI used was also tested for 
its various anion concentrations. The IC results of the samples tested are shown in Fig 3.28, 3.29, 3.30, 
3.31, 3.32 and 3.33. 
 






Figure 3.29: IC result of the reactor wall wash sample before the photocatalysis 
 






Figure 3.31: IC result of the DI  sample used for reactor washing 
 







Figure 3.33: IC result of the reactor wall wash sample after the oxidation of Isoflurane 
 
 
The IC reported a mass of 0.02 mg of fluorides from the reactor walls before the reaction in 
comparison to the 0.00026 mg of F- ions contained by the DI used for washing and, the 0.06 mg of 
fluorides from the reactor walls sampled after the degradation. This suggested an increase of 0.041 mg 
of fluoride ions produced in the reactor during the degradation of Isoflurane. Similarly, the IC reported 
a mass of 0.09 mg of chloride ions from the reactor walls before the reaction in comparison to the 0 mg 
contained by the DI used for washing and 0.4 mg of chloride ions from the reactor walls sampled after 
the degradation. This suggested an increase of 0.31 mg of chloride ions produced in the reactor during 
the degradation of Isoflurane. Theoretically, if all of the 911 ng/ml of Isoflurane that was present inside 
the reactor before turning on the UV was to degrade completely based on Equation 10, then 0.68 mg of 
chloride ions are expected to be produced in the reactor during the degradation. However, the 
possibility of these ions absorbing on to the catalyst surface is really high, but since the catalyst sheet 
wash was highly turbid its anionic composition could not be analyzed by the IC. 




Literature suggests that reaction of Isoflurane with the hydroxyl radicals proceeds via abstraction of the 
H atom which leads to the formation of CF3C(•)ClOCHF2 radical. It calls out a possible degradation 
mechanism of Isoflurane in the presence of hydroxyl radicals leading to the formation of 
pentafluoropropanol as a major product in addition to chlorodifluoroacetalydehyde, acetic acid, formic 
acid, formaldehyde, acetaldehyde as other byproducts in the presence of TiO2.
75 
C3H2ClF5O + OH°  C3F5OH + Cl° + H2O                                 ..…………………………Equation 11 
Of these potential byproducts, the GC-FID with the column installed could possibly detect the 
pentafluoropropanol but not the aldehydes. There were no significant additional peaks observed in the 
chromatogram after the UV irradiation suggesting that either it is improbable that any detectable 
amount of pentafluoropropanol was formed or that is did not have sufficient C-H bonds to be sensitive 
to the GC. 
This chlorine free radical obtained as shown in Eq (11) further attacks the Isoflurane in a chain reaction 
which eventually stops with either no Isoflurane remaining to be acted upon or reduced catalytic 
activity due to accumulation of byproducts onto the catalyst surface. This reaction mechanism is in line 
with our observation of an increase in the chloride ion concentration after the reaction.  
 
3.12.UV-Photocatalysis of Sevoflurane 
The 18W 254 nm UV lamp running the length of the reactor was fixed in the lamp holder. The walls of 
the reactor were lined with the catalyst coated sheet. Five (5) µl of liquid Sevoflurane was injected via 
the septum and allowed to volatilize. The peristaltic pump was used to promote uniform concentration 




Sevoflurane concentration was measured and analyzed as shown in Fig 3.34. 
 




With an initial concentration of 847 ng/ml, a 99.8% decrease in the Sevoflurane concentration was 
observed with a rate of decrease of 63.2 ng/ml/min the first 10 min of the irradiation and 0.5 ng/ml/min 
over the remaining 10 min when subjected to photocatalysis in the presence of TiO2. 
The 1st order decay curve fit the linear curve at some points, the plot of the instantaneous reaction rate 
constants at various time intervals was slightly different to the ones obtained in the case of Isoflurane 
as shown in Fig 3.35. The instantaneous reaction rate constants started with 0.25 min-1 for Sevoflurane 
and 0.0842 min-1 for Isoflurane, after which they increased with time but the Sevoflurane reaction rate 
decreased more sharply after it reached its maximum to 0.31 min-1when compared to the reaction rate 





Figure 3.35: Variation of instantaneous reaction rate constants and the concentration with time during 
the photocatalysis of Sevoflurane 
 
 
During the photocatalysis of Sevoflurane and Isoflurane, all the parameters such as the catalyst 
concentration, anesthetic gas concentration and the amount of water used for the medium preparation 
were kept constant hence the same amount of hydroxyl radical production is expected during both the 
experiments. However, the only difference is that Sevoflurane lacks chlorine while Isoflurane doesn’t. 
The available oxidizing species in addition to the existing hydroxyl radicals that can possibly cause the 
chain degradation mechanism during the photocatalysis of Sevoflurane is F- radicals. Since the F- 
radicals have a greater oxidizing power than the chloride radicals, they possibly oxidized Sevoflurane 
at a higher rate because of which in the first 10 min of the irradiation ~ 98% of the Sevoflurane was 





































































3.12.1.Testing for Byproducts of Photocatalysis of Sevoflurane 
The testing for oxidation intermediates or byproducts of Sevoflurane was performed similarly to that of 
Isoflurane as described in Section 3.11.1. The samples collected were analyzed for the free ion 
concentration of fluorides and chlorides using the IC. The IC results of the samples tested are shown in 
Fig 3.36, 3.37, 3.38, 3.39, 3.40 and 3.41. 
 
Figure 3.36: IC chromatogram of pre reaction reactor wall wash sample 
 





Figure 3.38: IC chromatogram of DI used for reactor wash 
 





Figure 3.40: IC chromatogram of post reaction reactor wall wash 
 
 
Figure 3.41: IC result of post reaction reactor wall wash 
 
The IC reported a mass of 0.0062 mg of fluorides from the reactor walls before the reaction in 
comparison to the 0.00026 mg of F- ions contained by the DI used for washing and, the 0.0084 mg of 




of fluoride ions produced in the reactor during the degradation of Sevoflurane. Theoretically, if the 
injected Sevoflurane was to oxidize completely into CO2and HF only based on Equation 12 then, 1.81 
mg of HF is expected if all of the created HF was captured and measured.  
2C4H3F7O + 5O2 + 4H2O  8CO2 + 14HF                                               ………………….Equation 12 
The increase in fluoride ion concentration post photocatalysis suggests the presence of free fluoride 
radicals which would have been generated during the oxidation of Sevoflurane with OHo. These 
fluoride ions produced could be a possible cause for the acceleration of the instantaneous reaction rate 
with time as depicted in Fig 3.35. 
There is no literature reported on the mechanism of the degradation of Sevoflurane in the presence of 
hydroxyl radicals. However, literature reports HF and CO2 as the final two oxidation products of 
Sevoflurane in a closed loop reactor, with TiO2 as a photocatalyst coated on a glass tubular support in 
















4.Conclusions and Future Work 
4.1.Summary of Results 
In this project, a treatment system was successfully designed and tested to completely oxidize three 
common anesthetic gases (Halothane, Isoflurane and Sevoflurane) that are vented untreated into the 
environment from the medical facilities. Gas chromatography with an FID and an IC instrument were 
used for the quantification and identification of these gases and their oxidation by-products. A set of 
process and environmental parameters were tested for their influence on the anesthetic gas degradation 
rate.  
UV-photocatalysis with a 254 nm light source and TiO2 photocatalyst was found to be the most 
efficient advanced oxidation process in degrading 99.9 % of the 1296 ng/ml of Halothane among the 
ones tested. This process demonstrated similar degradation efficiency with 847 ng/ml of Sevoflurane 
and 911 ng/ml of Isoflurane. UV-photolysis and UV-ozonation both gave 36% degradation with 1296 
ng/ml of Halothane. TiO2 was found to be more efficient than ZnO as a photocatalyst since it degraded 
100% of injected 1111.4 ng/ml of Halothane in comparison to the 29% by ZnO due to its speculated 
greater absorption coefficient in the incident light wavelength region of 254 nm. TiO2in the presence of 
1511 ng/ml of Halothane gave 87% degradation with a 9 W 254 nm light source when compared to 
5.4% degradation with the 365 nm light source due to its greater absorption coefficient in the 254 nm 
region.  
Of the three support surfaces tested, the plain, flat aluminum support was found to be more effective 
due to its larger illuminated area, uniform surface and lack of absorption of the TiO2 molecules into the 
bulk of the support surface. The photocatalytic degradation rate increased with increase in the incident 




radicals. For a fixed amount of catalyst, the rate of degradation decreased with increase in the reactant 
inlet concentration due to greater competition for adsorption on to the available catalytic sites. For a 
fixed reactant inlet concentration, the rate of degradation increased up to a limit with increase in 
catalyst loading due to increased generation of hydroxyl radicals, after which for any further increase 
the rate of degradation decreased due to catalyst overloading. 
The instantaneous rate constants for Halothane decreased with time due to depletion of the reactant or 
reduced catalyst activity, however, the instantaneous reaction rate constants, when plotted against time 
for Isoflurane and Sevoflurane was found to increase, reach a maximum and then decrease with time. It 
was determined that both Sevoflurane and Isoflurane underwent a chain reaction mechanism whereby 
initially the hydroxyl radicals acted as a primary oxidizing agent which then generated halogenated free 
radicals (Fo and Clo respectively) which accelerated the chain degradation. This conclusion was 
supported by the IC analysis that demonstrated the production of chloride and fluoride radicals from 
the UV-photocatalysis of Isoflurane and Sevoflurane. The results presented here suggest that UV-
photocatalysis is a promising technique to treat out any leftover anesthetic gas before being released 
out into the environment. 
 
4.2.Recommendations 
To ensure that no further anesthetic gases are released untreated into the environment this treatment 
system should be installed in the healthcare facilities as a final degradation technique after the initial 
anesthetic recovery has been done.  
In a worst case scenario, if the anesthetic recovery setup present before the photocatalytic oxidation 
system fails to capture the emitted anesthetic gas, assuming that the anesthetic gas had a flow rate of 




mentioned in Equation 12 is followed. This amount corresponds to 127 ppm HF inside the photoreactor 
which over time has the potential to damage the equipment used in the setup. The below 
recommendations are being suggested as the probable next steps: 
1. Test the degradation efficiency of UV-photocatalysis in a flow through system  
2. Test the setup in a small-scale onsite system to determine the actual inlet anesthetic gas conditions 
(temperature, pressure, humidity, pH and oxygen concentration) and their effect on the degradation 
efficiency 
3. Use BET (Brunauer-Emmett-Teller) theory and testing to obtain an estimate of the actual catalyst 
surface area available for the absorption of the anesthetic gas 
4. Test for catalyst deactivation in a flow through system and install a sensor at the exit end to 
determine and identify when the anesthetic gas concentrations are higher than expected 
5. Confirm the oxidation by-products of Sevoflurane and Isoflurane and ensure sufficient safety 
measures are in place to handle any harmful emissions like HF or HCl 
6. Determine ways to handle and accurately quantify the highly volatile Desflurane and test its 
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TESTING FOR BYPRODUCTS OF UV-PHOTOCATALYSIS 
By product Estimation with Sevoflurane 
a)2C4H3F7O + 5O2 + 4H2O  8 CO2 + 14 HF 
5 ul of sevo = 3.81x10-5 moles 
1 mol of Sevo  7 mol of HF 
Therefore,  
3.81x10-5 moles  5.34 mg of HF 
 
b) C4H3F7O  HF + C4H2F6O 
   1 mol of Sevo  1 mol of HF 
Therefore,  
3.81x10-5 moles  0.762 mg of HF 
 
By product Estimation with Isoflurane 
a) C3H2ClF5O + H2O C3F5OH + HCl+H2O 
5 ul of iso = 4.05x10-5 moles 
1 mol of Iso  1 mol of HCl 
Therefore,  




Calculate the absorbance of Halothane using the absorption cross section 
A=Abs. cross section (cm2/molecule) * absorption path length(cm) * density of absorber 
(molecule/cm3) 
 At 254 nm with 1400 ng/ml of Halothane 
A= 4.5x10-20* 10.2*1.62x1019/3787 
   =0.00196 
T=10-A 
=10-0.00196 = 1 – abs fraction 
Abs fraction = 0.0045 
 
3.1.2UV-Ozonation 
Calculate the concentration of ozone produced in the reactor 
T = 10-A where A is the absorbance obtained using the spectrometer 
T =10-1.808533 
    =0.016 
 
Concentration (molecule/cm3) = Ln(T)/ (Abs cross section at 254 nm * path length of the cell) 
                                                 = Ln (0.016)/ (-1.159 x 10-17 x 10) 
                                                 =2.8 x 1016 molecules/cm3 
 = 1.1 x 1020 molecules 






Calculate the absorbance of ozone using the absorption cross section 
A=Abs. cross section (cm2/molecule) * absorption path length(cm) * density of absorber 
(molecule/cm3) 
At 254 nm with 1.1 x1020of ozone 
A= 1.5x10-17* 10.2*1.1x1020/3787 
   =4.44 
Abs fraction= 0.9999 
 
3.4 Influence of the incident light source wavelength on the anesthetic gas degradation rate 
 Number of photons emitted by 9W lamp at 254 nm: 
 
E= ((6.626x10-34) X (3x108))/ (254x10-9) 
=7.83x10-19 J 
Number of photons in the 9W lamp (assuming 33.3% conversion) = 3/7.83x10-19 J 
                                                                                                           = 3.83x1018 photons/sec 
Similarly,  
Number of photons emitted by 9W lamp at 365 nm = 5.50x1018 photons/sec 
 
Therefore, with an absorption fraction of 0.00441 @ 254 nm and 1.17x10-16 @ 365 nm 
 In 30 min at 254 nm, Halothane will absorb 3.04x1019 photons and at 365 nm Halothane will absorb 
1.17x1016 photons 
 
 
 
 
 
